In March 2025, the company announced new plans for any direct-to-consumer providing of its Wegovy weight loss drug. The company set up a new pharmacy, named NovoCare, which would cost shoppers $499 per month for access to the drug, fewer than 50 % the expense of the drug as a result of other pharmaceutical distribution networks.[53]Wegovy® contain